These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38870546)

  • 1. Changes in the incidence of cannabis-related disorders after the Cannabis Act and the COVID-19 pandemic in Québec, Canada.
    Martínez P; Huynh C; Massamba V; Zefania I; Rochette L; Vasiliadis HM; Nazif-Munoz JI
    Int J Drug Policy; 2024 Jun; 129():104484. PubMed ID: 38870546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in prenatal cannabis-related diagnosed disorders after the Cannabis Act and the COVID-19 pandemic in Quebec, Canada.
    Nazif-Munoz JI; Martínez P; Huỳnh C; Massamba V; Zefania I; Rochette L; Vasiliadis HM
    Addiction; 2024 Jun; ():. PubMed ID: 38898560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada.
    Myran DT; Gaudreault A; Konikoff L; Talarico R; Liccardo Pacula R
    JAMA Netw Open; 2023 Oct; 6(10):e2336113. PubMed ID: 37796504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
    Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
    JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
    Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M
    Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic.
    Armstrong MJ; Cantor N; Smith BT; Jesseman R; Hobin E; Myran DT
    Drug Alcohol Rev; 2022 Jul; 41(5):1131-1135. PubMed ID: 35316855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in cannabis involvement in emergency department visits for anxiety disorders after cannabis legalization: a repeated cross-sectional study.
    McCarthy SDS; Xiao J; Pugliese M; Perrault-Sequeira L; Myran DT
    Lancet Reg Health Am; 2024 Aug; 36():100815. PubMed ID: 38974381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Youth Cannabis Use After an Increase in Cannabis Minimum Legal Age in Quebec, Canada.
    Nguyen HV; Mital S
    JAMA Netw Open; 2022 Jun; 5(6):e2217648. PubMed ID: 35713901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unintentional pediatric poisonings before and during the COVID-19 pandemic: A population-based study.
    Myran DT; Gaudreault A; McCarthy SDS; Pugliese M; Tanuseputro P; Finkelstein Y
    Am J Emerg Med; 2024 Feb; 76():185-192. PubMed ID: 38086185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the Incidence of New-Onset Anorexia Nervosa and Atypical Anorexia Nervosa Among Youth During the COVID-19 Pandemic in Canada.
    Agostino H; Burstein B; Moubayed D; Taddeo D; Grady R; Vyver E; Dimitropoulos G; Dominic A; Coelho JS
    JAMA Netw Open; 2021 Dec; 4(12):e2137395. PubMed ID: 34874405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the impact of the early stages of the COVID-19 pandemic period on youth cannabis use: adjusted annual changes between the pre-COVID and initial COVID-lockdown waves of the COMPASS study.
    Leatherdale ST; Bélanger RE; Gansaonré RJ; Patte KA; deGroh M; Jiang Y; Haddad S
    BMC Public Health; 2021 Jun; 21(1):1181. PubMed ID: 34154564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic Stringency Measures and Hospital Admissions for Eating Disorders.
    Roumeliotis N; Carwana M; Charland K; Trudeau O; Benigeri M; Diop M; Agostino H; Zinszer K; Amsdr I; Forgeot d'Arc B; Côté S; Basta NE; Fontela P; Gantt S; Klassen TP; Quach C; Doan Q;
    JAMA Pediatr; 2024 Jul; ():. PubMed ID: 38976259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis-related Hospitalizations Among Youth in Canada Before and After Cannabis Legalization.
    Auger N; Luu TM; Ayoub A; Bilodeau-Bertrand M; Lo E; Low N
    J Addict Med; 2021 May-Jun 01; 15(3):245-247. PubMed ID: 33060465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recreational cannabis legalization on rates of traffic injury in Canada.
    Walker M; Saarela O; Mann R; Carpino M; Cusimano MD
    Addiction; 2023 Aug; 118(8):1517-1526. PubMed ID: 36908044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
    Yao X; McFaull SR; Champagne AS; Thompson W
    BMC Public Health; 2023 Aug; 23(1):1483. PubMed ID: 37537534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trend of poisonings before and after the COVID-19 pandemic.
    Behnoush AH; Bazmi E; Khalaji A; Jafari-Mehdiabad A; Barzegari N; Dehpour AR; Behnoush B
    Sci Rep; 2024 Jan; 14(1):2098. PubMed ID: 38267612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006-2015.
    Maloney-Hall B; Wallingford SC; Konefal S; Young MM
    Health Promot Chronic Dis Prev Can; 2020 Jun; 40(5-6):176-183. PubMed ID: 32529977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in cannabis-related emergency department visits and hospitalizations among children aged 0-11 years in Canada from 2015 to 2021: spotlight on cannabis edibles.
    Varin M; Champagne A; Venugopal J; Li L; McFaull SR; Thompson W; Toigo S; Graham E; Lowe AM
    BMC Public Health; 2023 Oct; 23(1):2067. PubMed ID: 37872564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
    Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
    JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
    Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
    JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.